XML 81 R60.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
entity
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Segment Reporting [Abstract]      
Number of reportable segments | entity 1    
Segment Reporting Information [Line Items]      
Research and development $ 7,778 $ 7,559  
General and administrative 2,958 2,682  
Net loss (11,209) (11,827)  
Total segment assets 28,144   $ 28,178
Reportable Segment      
Segment Reporting Information [Line Items]      
Contract and grant reimbursements (489) (67)  
General and administrative 1,087 919  
Professional fees and other general and administrative expenses 1,866 1,762  
Other segment items 473 1,587  
Net loss 11,209 11,827  
Total segment assets 28,144   $ 28,178
Clinical trial expenses | Reportable Segment      
Segment Reporting Information [Line Items]      
Research and development 4,192 2,302  
Employee related research and development expenses | Reportable Segment      
Segment Reporting Information [Line Items]      
Research and development 2,298 2,243  
Chemistry, manufacturing and controls expenses | Reportable Segment      
Segment Reporting Information [Line Items]      
Research and development 646 1,194  
Other research and development expenses | Reportable Segment      
Segment Reporting Information [Line Items]      
Research and development $ 1,136 $ 1,887